找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Cancer Policy: Pharmaceutical Safety; June M. McKoy,Dennis P. West Book 2019 Springer Nature Switzerland AG 2019 Drug Safety.Health.Oncolo

[復(fù)制鏈接]
樓主: 從未迷惑
31#
發(fā)表于 2025-3-26 21:11:11 | 只看該作者
32#
發(fā)表于 2025-3-27 02:41:53 | 只看該作者
33#
發(fā)表于 2025-3-27 06:35:09 | 只看該作者
Current Topics in Behavioral Neurosciencese electronic health records. For victims of adverse drug reactions, tort lawsuits filed in the courts help compensate for the harm suffered and may also serve as warnings to manufacturers to improve drug safety to avoid future legal liability. While encouraging developments have occurred, new and ex
34#
發(fā)表于 2025-3-27 09:44:28 | 只看該作者
New Discoveries on the β-Hydride Eliminationerfeit products that compromise patient safety. The Food and Drug Administration plays a key role in preventing and managing pharmaceutical shortages, largely through regulations requiring early notification of manufacturing interruptions. Other proposed strategies similarly target upstream causes a
35#
發(fā)表于 2025-3-27 16:18:41 | 只看該作者
36#
發(fā)表于 2025-3-27 20:49:19 | 只看該作者
37#
發(fā)表于 2025-3-27 22:24:56 | 只看該作者
Key Elements in Adverse Drug Reactions Safety Signals: Application of Legal Strategies,n, particularly for cancer patients. If counted as a separate cause of death, adverse drug reactions would represent the fourth leading cause of death in the United States. Several legal strategies are available to help mitigate their occurrences and to compensate victims for the harm that results f
38#
發(fā)表于 2025-3-28 03:13:31 | 只看該作者
39#
發(fā)表于 2025-3-28 08:50:18 | 只看該作者
The Drug Shortage Crisis in the United States: Impact on Cancer Pharmaceutical Safety,s safety risks for patients and substantial burden on providers and the healthcare system. Multifaceted drivers of this complex problem include manufacturing disruptions, raw material shortages, regulatory issues, market dynamics, and limited financial incentives that reward quality and production o
40#
發(fā)表于 2025-3-28 11:19:38 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-16 07:06
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
资源县| 崇州市| 汾西县| 萍乡市| 浙江省| 华池县| 沙洋县| 南川市| 得荣县| 云阳县| 南部县| 诸城市| 兴海县| 瑞丽市| 昌平区| 泉州市| 台湾省| 西乌| 洛南县| 台南县| 铜川市| 西青区| 金山区| 门源| 安图县| 四平市| 家居| 来安县| 清新县| 右玉县| 新丰县| 宜都市| 泰宁县| 桂林市| 江孜县| 疏勒县| 建湖县| 巴里| 天水市| 仁怀市| 郸城县|